A Novel NGF Receptor Agonist B355252 Ameliorates Neuronal Loss and Inflammatory Responses in a Rat Model of Cerebral Ischemia

References

• Cheng NT, Kim AS. Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. Neurohospitalist. 2015;5(3):101–109. doi:10.1177/1941874415583116
   PubMed Web of Science ®Google Scholar
• Lanfranconi S, Locatelli F, Corti S, et al. Growth factors in ischemic stroke. J Cell Mol Med. 2011;15(8):1645–1687.
   PubMed Web of Science ®Google Scholar
• Oliveira SL, Pillat MM, Cheffer A, Lameu C, Schwindt TT, Ulrich H. Functions of neurotrophins and growth factors in neurogenesis and brain repair. Cytometry A. 2013;83(1):76–89. doi:10.1002/cyto.a.22161
   PubMed Web of Science ®Google Scholar
• Ren JM, Finklestein SP. Growth factor treatment of stroke. Curr Drug Targets CNS Neurol Disord. 2005;4(2):121–125. doi:10.2174/1568007053544101
   PubMedGoogle Scholar
• Kolb B, Morshead C, Gonzalez C, et al. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats. J Cereb Blood Flow Metab. 2007;27(5):983–997. doi:10.1038/sj.jcbfm.9600402
   PubMed Web of Science ®Google Scholar
• Belayev L, Khoutorova L, Zhao KL, Davidoff AW, Moore AF, Cramer SC. A novel neurotrophic therapeutic strategy for experimental stroke. Brain Res. 2009;1280:117–123. doi:10.1016/j.brainres.2009.05.030
   PubMed Web of Science ®Google Scholar
• Thorne RG, Frey WH. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet. 2001;40(12):907–946. doi:10.2165/00003088-200140120-00003
   PubMed Web of Science ®Google Scholar
• Miller G. Drug targeting. Breaking down barriers. Science. 2002;297(5584):1116–1118. doi:10.1126/science.297.5584.1116
   PubMed Web of Science ®Google Scholar
• Saragovi HU, Gehring K. Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol Sci. 2000;21(3):93–98. doi:10.1016/S0165-6147(99)01444-3
   PubMed Web of Science ®Google Scholar
• Dago L, Bonde C, Peters D, et al. NS 1231, a novel compound with neurotrophic-like effects in vitro and in vivo. J Neurochem. 2002;81(1):17–24. doi:10.1046/j.1471-4159.2002.00803.x
   PubMed Web of Science ®Google Scholar
• Williams AL, Dandepally SR, Gilyazova N, Witherspoon SM, Ibeanu G. Microwave-assisted synthesis of 4-chloro-N-(naphthalen-1-ylmethyl)-5-(3-(piperazin-1-yl)phenoxy)thiophene-2-sulfo namide (B-355252): a new potentiator of Nerve Growth Factor (NGF)-induced neurite outgrowth. Tetrahedron. 2010;66(50):9577–9581. doi:10.1016/j.tet.2010.09.028
   PubMed Web of Science ®Google Scholar
• Gliyazova NS, Huh EY, Ibeanu GC. A novel phenoxy thiophene sulphonamide molecule protects against glutamate evoked oxidative injury in a neuronal cell model. BMC Neurosci. 2013;14:93. doi:10.1186/1471-2202-14-93
   PubMed Web of Science ®Google Scholar
• Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142.
   PubMed Web of Science ®Google Scholar
• Fuxe K, Bjelke B, Andbjer B, Grahn H, Rimondini R, Agnati LF. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport. 1997;8(11):2623–2629. doi:10.1097/00001756-199707280-00040
   PubMed Web of Science ®Google Scholar
• Abeysinghe HC, Bokhari L, Dusting GJ, Roulston CL. Brain remodelling following endothelin-1 induced stroke in conscious rats. PLoS One. 2014;9(5):e97007. doi:10.1371/journal.pone.0097007
   PubMed Web of Science ®Google Scholar
• Cordova CA, Jackson D, Langdon KD, Hewlett KA, Corbett D. Impaired executive function following ischemic stroke in the rat medial prefrontal cortex. Behav Brain Res. 2014;258:106–111. doi:10.1016/j.bbr.2013.10.022
   PubMed Web of Science ®Google Scholar
• Blasi F, Whalen MJ, Ayata C. Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats. J Cereb Blood Flow Metab. 2015;35(6):977–984. doi:10.1038/jcbfm.2015.7
   PubMed Web of Science ®Google Scholar
• Tennant KA, Jones TA. Sensorimotor behavioral effects of endothelin-1 induced small cortical infarcts in C57BL/6 mice. J Neurosci Methods. 2009;181(1):18–26. doi:10.1016/j.jneumeth.2009.04.009
   PubMed Web of Science ®Google Scholar
• Lee B, Clarke D, Al Ahmad A, et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest. 2011;121(8):3005–3023. doi:10.1172/JCI46358
   PubMed Web of Science ®Google Scholar
• Wu CC, Wang LC, Su YT, Wei WY, Tsai KJ. Synthetic alpha5beta1 integrin ligand PHSRN is proangiogenic and neuroprotective in cerebral ischemic stroke. Biomaterials. 2018;185:142–154. doi:10.1016/j.biomaterials.2018.09.014
   PubMed Web of Science ®Google Scholar
• Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK. Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods. 2008;173(2):286–290. doi:10.1016/j.jneumeth.2008.06.013
   PubMed Web of Science ®Google Scholar
• Wu CC, Wang IF, Chiang PM, Wang LC, Shen CJ, Tsai KJ. G-CSF-mobilized Bone Marrow Mesenchymal Stem Cells Replenish Neural Lineages in Alzheimer’s Disease Mice via CXCR4/SDF-1 Chemotaxis. Mol Neurobiol. 2016.
   Web of Science ®Google Scholar
• Wu CC, Lien CC, Hou WH, Chiang PM, Tsai KJ. Gain of BDNF Function in Engrafted Neural Stem Cells Promotes the Therapeutic Potential for Alzheimer’s Disease. Sci Rep. 2016;6:27358. doi:10.1038/srep27358
   PubMed Web of Science ®Google Scholar
• Schaar KL, Brenneman MM, Savitz SI. Functional assessments in the rodent stroke model. Exp Transl Stroke Med. 2010;2(1):13. doi:10.1186/2040-7378-2-13
   PubMedGoogle Scholar
• Alamri FF, Shoyaib AA, Biggers A, Jayaraman S, Guindon J, Karamyan VT. Applicability of the grip strength and automated von Frey tactile sensitivity tests in the mouse photothrombotic model of stroke. Behav Brain Res. 2018;336:250–255. doi:10.1016/j.bbr.2017.09.008
   PubMed Web of Science ®Google Scholar
• Petullo D, Masonic K, Lincoln C, Wibberley L, Teliska M, Yao DL. Model development and behavioral assessment of focal cerebral ischemia in rats. Life Sci. 1999;64(13):1099–1108. doi:10.1016/S0024-3205(99)00038-7
   PubMed Web of Science ®Google Scholar
• Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke. 2002;33(10):2478–2484. doi:10.1161/01.STR.0000032302.91894.0F
   PubMed Web of Science ®Google Scholar
• Wu CC, Jin LW, Wang IF, et al. HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies. EMBO Mol Med. 2020;12(6):e10622. doi:10.15252/emmm.201910622
   PubMed Web of Science ®Google Scholar
• Allen LM, Hasso AN, Handwerker J, Farid H. Sequence-specific MR imaging findings that are useful in dating ischemic stroke. Radiographics. 2015;32(5):1285–1297. doi:10.1148/rg.325115760
   Google Scholar
• Rodrigo R, Fernandez-Gajardo R, Gutierrez R, et al. Oxidative stress and pathophysiology of ischemic stroke: novel therapeutic opportunities. CNS Neurol Disord Drug Targets. 2013;12(5):698–714. doi:10.2174/1871527311312050015
   PubMed Web of Science ®Google Scholar
• Popa-Wagner A, Carmichael ST, Kokaia Z, Kessler C, Walker LC. The response of the aged brain to stroke: too much, too soon? Curr Neurovasc Res. 2007;4(3):216–227. doi:10.2174/156720207781387213
   PubMed Web of Science ®Google Scholar
• Zhou Z, Lu J, Liu WW, et al. Advances in stroke pharmacology. Pharmacol Ther. 2018;191:23–42.
   PubMed Web of Science ®Google Scholar
• Schwamm LH, Koroshetz WJ, Sorensen AG, et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke. 1998;29(11):2268–2276.
   PubMed Web of Science ®Google Scholar
• Yang Q, Huang Q, Hu Z, Tang X. Potential Neuroprotective Treatment of Stroke: targeting Excitotoxicity, Oxidative Stress, and Inflammation. Front Neurosci. 2019;13:1036. doi:10.3389/fnins.2019.01036
   PubMed Web of Science ®Google Scholar
• Genovese T, Mazzon E, Paterniti I, Esposito E, Bramanti P, Cuzzocrea S. Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats. Brain Res. 2011;1372:92–102. doi:10.1016/j.brainres.2010.11.088
   PubMed Web of Science ®Google Scholar
• Barua S, Kim JY, Yenari MA, Lee JE. The role of NOX inhibitors in neurodegenerative diseases. IBRO Rep. 2019;7:59–69. doi:10.1016/j.ibror.2019.07.1721
   PubMedGoogle Scholar
• Collino M, Aragno M, Mastrocola R, et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol. 2006;530(1–2):70–80. doi:10.1016/j.ejphar.2005.11.049
   PubMed Web of Science ®Google Scholar
• Friedman WJ, Greene LA. Neurotrophin signaling via Trks and p75. Exp Cell Res. 1999;253(1):131–142. doi:10.1006/excr.1999.4705
   PubMed Web of Science ®Google Scholar
• Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10(3):381–391. doi:10.1016/S0959-4388(00)00092-1
   PubMed Web of Science ®Google Scholar
• Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272–280. doi:10.1016/S0959-4388(00)00208-7
   PubMed Web of Science ®Google Scholar
• Bibel M, Barde YA. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev. 2000;14(23):2919–2937. doi:10.1101/gad.841400
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736. doi:10.1146/annurev.neuro.24.1.677
   PubMed Web of Science ®Google Scholar
• Nusser N, Gosmanova E, Zheng Y, Tigyi G. Nerve growth factor signals through TrkA, phosphatidylinositol 3-kinase, and Rac1 to inactivate RhoA during the initiation of neuronal differentiation of PC12 cells. J Biol Chem. 2002;277(39):35840–35846. doi:10.1074/jbc.M203617200
   PubMed Web of Science ®Google Scholar
• Gliyazova NS, Ibeanu GC. The Chemical Molecule B355252 is Neuroprotective in an In Vitro Model of Parkinson’s Disease. Cell Mol Neurobiol. 2016;36(7):1109–1122. doi:10.1007/s10571-015-0304-5
   PubMed Web of Science ®Google Scholar
• Chimeh U, Zimmerman MA, Gilyazova N, Li PA. B355252, a novel small molecule, confers neuroprotection against cobalt chloride toxicity in mouse hippocampal cells through altering mitochondrial dynamics and limiting autophagy induction. Int J Med Sci. 2018;15(12):1384–1396. doi:10.7150/ijms.24702
   PubMed Web of Science ®Google Scholar
• Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1–2):53–68. doi:10.1016/j.jneuroim.2006.11.014
   PubMed Web of Science ®Google Scholar
• Micera A, Properzi F, Triaca V, Aloe L. Nerve growth factor antibody exacerbates neuropathological signs of experimental allergic encephalomyelitis in adult Lewis rats. J Neuroimmunol. 2000;104(2):116–123. doi:10.1016/S0165-5728(99)00272-6
   PubMed Web of Science ®Google Scholar
• Reinshagen M, Rohm H, Steinkamp M, et al. Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology. 2000;119(2):368–376. doi:10.1053/gast.2000.9307
   PubMed Web of Science ®Google Scholar
• Ehrhard PB, Ganter U, Stalder A, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci U S A. 1993;90(12):5423–5427. doi:10.1073/pnas.90.12.5423
   PubMed Web of Science ®Google Scholar
• Caroleo MC, Costa N, Bracci-Laudiero L, Aloe L. Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. J Neuroimmunol. 2001;113(2):193–201. doi:10.1016/S0165-5728(00)00441-0
   PubMed Web of Science ®Google Scholar
• Prencipe G, Minnone G, Strippoli R, et al. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA. J Immunol. 2014;192(7):3345–3354. doi:10.4049/jimmunol.1300825
   PubMed Web of Science ®Google Scholar
• la Sala A, Corinti S, Federici M, Saragovi HU, Girolomoni G. Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis. J Leukoc Biol. 2000;68(1):104–110.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460–469. doi:10.1016/j.molmed.2007.09.002
   PubMed Web of Science ®Google Scholar
• Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003;24(7):358–363. doi:10.1016/S1471-4906(03)00139-X
   PubMed Web of Science ®Google Scholar
• Liew FY, Xu D, Brint EK, O’Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol. 2005;5(6):446–458. doi:10.1038/nri1630
   PubMed Web of Science ®Google Scholar
• Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat Immunol. 2005;6(12):1198–1205. doi:10.1038/ni1274
   PubMed Web of Science ®Google Scholar
• Pajouhesh H, Lenz GR. Medicinal chemical properties of successful central nervous system drugs. NeuroRx. 2005;2(4):541–553. doi:10.1602/neurorx.2.4.541
   PubMedGoogle Scholar
• Palm K, Luthman K, Ros J, Grasjo J, Artursson P. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J Pharmacol Exp Ther. 1999;291(2):435–443.
   PubMed Web of Science ®Google Scholar
• Osterberg T, Norinder U. Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics. J Chem Inf Comput Sci. 2000;40(6):1408–1411. doi:10.1021/ci000065l
   PubMedGoogle Scholar